Tissue Regenix's market cap is currently ―. The company's EPS TTM is p-0.019; its P/E ratio is -34.25; Tissue Regenix is scheduled to report earnings on September 4, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.95M	$ 6.17M	$ 7.71M	$ 6.56M	$ 12.97M
Total Assets	$ 46.04M	$ 44.49M	$ 46.22M	$ 34.31M	$ 50.33M
Total Debt	$ 9.61M	$ 8.56M	$ 7.95M	$ 5.37M	$ 7.22M
Net Debt	$ 3.66M	$ 2.39M	$ 238.00K	$ -1.19M	$ -5.75M
Total Liabilities	$ 15.64M	$ 13.46M	$ 12.83M	$ 8.22M	$ 12.06M
Stockholders Equity	$ 31.25M	$ 31.96M	$ 34.34M	$ 26.77M	$ 39.03M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

Tissue Regenix Earnings and Revenue History

Income Statement >

Tissue Regenix Debt to Assets

Balance Sheet >

Tissue Regenix Cash Flow

Cash Flow >

Tissue Regenix Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing